PRIOR AUTHORIZATION BASICS
Quick Answer
Short answer: Most employer and ACA plans must decide a Foundayo prior authorization within 15 days (72 hours if urgent), and many decide sooner. Most insurers require BMI ≥30 (or ≥27 with a qualifying condition), documented lifestyle attempts, and sometimes prior medication trials—but requirements vary by plan.
What do I need for Foundayo prior authorization?
- BMI documentation: ≥30 or ≥27 with comorbidity (hypertension, diabetes, sleep apnea)
- Lifestyle modification: 3-6 months of documented diet/exercise
- Step therapy: Some insurers require trying cheaper meds first
Who this guide is for
Patients starting the PA process, waiting on a decision, or recently denied and considering next steps.
Your GLP-1 coverage,
denied approved
✓ Free Templates✓ Premium Support Available
I was denied coverage for...
Get starteddenied approved
Honest Care helps patients fight back:
Evidence-backed appeal letters — plus personalized guidance to appeal with confidence.
"I found Honest Care online and was very impressed with the letter... the appeal worked!"
"My Appeal was approved the next day. Thank you Honest Care!"
UNDERSTANDING THE BASICS
What Is Prior Authorization?
Prior authorization (PA) is insurance approval required before your pharmacy can fill your Foundayo prescription. Your insurer reviews whether you meet their medical necessity criteria (their standards for deciding if a treatment is medically needed for you)—things like BMI (body mass index), comorbidities (other health conditions like diabetes or high blood pressure), and sometimes prior medication trials.[1] This is standard for GLP-1 weight loss medications, not a denial.
Key Point
You can't submit the PA yourself—your doctor's office handles it. But you can prepare documentation ahead of time and follow up to speed the process.
Think of it this way: your doctor writes the prescription, but your insurance company needs to verify you qualify under their guidelines before they'll pay for it. For most employer and ACA plans, federal rules require a decision within 15 days (72 hours if urgent); complete documentation helps avoid delays.[4]
Why Do Insurers Require PA for Foundayo?
- Cost control: GLP-1 weight loss medications have list prices of $1,000+/month. Insurers want to verify medical necessity before covering them.
- Verify eligibility: They confirm you meet FDA-approved criteria (BMI ≥30 or ≥27 with comorbidity).[1]
- Step therapy: Some insurers require you to try cheaper medications first.
STEP BY STEP
The PA Process
Here's what happens after your doctor writes a Foundayo prescription:
Doctor Writes Prescription
Your provider sends the Rx to your pharmacy. This starts the process.
Pharmacy Attempts to Fill
The pharmacy runs it through your insurance. The system automatically flags that PA is required.
Doctor's Office Submits PA
Your provider's office is notified and submits the PA request with your medical documentation. You don't submit this directly.
Insurer Reviews
The insurance company checks if you meet their specific criteria for Foundayo coverage.
Decision Communicated
You'll get approved, denied, or they'll request more information. Your doctor's office usually hears first.
Timeline Expectations
| Scenario | Expected Timeline | Your Action |
|---|---|---|
| Complete documentation | Often faster than the legal maximum; varies by plan | Wait for notification |
| Standard (non-urgent) request | Up to 15 days (one 15-day extension allowed) under federal rules for most employer and ACA plans | Follow up after 5 days |
| Expedited/urgent | 72 hours (federal rule for urgent requests in employer and ACA plans)[4] | Ask doctor to flag as urgent |
| Missing info/complex | The plan must say what's missing; you get at least 45 days to send it | Provide requested docs ASAP |
Note: These are federal maximums for most employer and ACA plans; state law can set shorter limits for state-regulated plans, and Medicare Part D and the Medicare GLP-1 Bridge have their own timelines. CMS's 2026 prior authorization rule (7 days standard, 72 hours urgent) covers medical services in Medicare Advantage, Medicaid and CHIP and excludes drugs, so it doesn't apply to Foundayo.
Speed Tip
Incomplete documentation is the #1 cause of delays. Come to your appointment prepared with your weight history, comorbidity diagnoses, and prior weight loss attempts documented. Foundayo prior authorization checklist →
PRIOR AUTH REQUIREMENTS
What You Need to Qualify
While exact criteria vary by insurer, here are the standard requirements for Foundayo prior authorization. Some insurers also require step therapy (trying other medications first).
| Requirement | Standard Threshold | Notes |
|---|---|---|
| BMI | ≥30 (obese) OR ≥27 with comorbidity | Some insurers stricter (e.g., BCBS MI: ≥35 as of 2024) |
| Qualifying comorbidities | High blood pressure, type 2 diabetes, high cholesterol, sleep apnea | At least one if BMI 27-29.9 |
| Lifestyle modification | 3-6 months documented (varies) | Diet/exercise, some require programs |
| Step therapy | Varies by insurer | May require prior med trials |
Qualifying Comorbidities
These health conditions qualify you for Foundayo coverage at BMI 27-29.9. Make sure your medical records include the proper diagnosis codes (ICD-10 codes are the standard billing codes doctors use):[2]
- High blood pressure — code I10
- Type 2 diabetes — code E11
- High cholesterol (dyslipidemia) — code E78.5
- Sleep apnea (obstructive) — code G47.33
What Is Step Therapy?
Some insurers require you to try other weight loss medications first before approving Foundayo. Most step therapy ladders start with older, less expensive options:
- Phentermine — 3 months typical trial (most common first step)
- Contrave (naltrexone/bupropion) — 3 months
- Qsymia (phentermine/topiramate) — 3 months
- Other GLP-1s — Less common as step therapy since they're similarly priced; some plans may require trying oral Wegovy before injectable options
Already Tried These?
If you've previously tried weight loss medications, document: dates, doses, duration, outcomes, and why you stopped. Had side effects or contraindications? Note those too—this can satisfy step therapy requirements.
Step therapy is one of the most common reasons for delays. Come prepared with your prior medication history.
Want your insurer's exact criteria? Foundayo prior authorization requirements by insurer →
NEW DRUG — POLICIES FORMING
Requirements by Insurer
Foundayo Just Approved (April 2026)
Foundayo received FDA approval on April 1, 2026. Insurers are still developing their specific coverage policies. Expect requirements similar to other GLP-1s, but verify with your plan directly.
What to Expect (Based on GLP-1 Patterns)
Based on how insurers handle other GLP-1 weight loss medications:
- Most commercial plans require prior authorization for weight loss GLP-1s[6]
- Most require: BMI documentation, lifestyle modification attempts, sometimes step therapy
- Initial approval periods: Typically 6-12 months, then renewal required
- 2026 trend: Many insurers are tightening (not loosening) GLP-1 coverage
Checking Your Specific Plan
- Call the number on your insurance card
- Ask: "What are the prior authorization requirements for Foundayo (orforglipron)?"
- Request: The PA criteria document or policy bulletin
- Get it in writing: Ask them to send the criteria via email or mail
2026 Coverage Trends
Many insurers are restricting GLP-1 coverage for weight loss in 2026:
| Insurer Type | 2026 Trend | Notes |
|---|---|---|
| Commercial (employer) | Mixed—varies by employer | Some adding, some dropping coverage |
| Individual/Small Group | Restricting | Health New England, others dropping weight loss GLP-1s |
| Medicare Part D | Expanded (Bridge live) | Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027): Wegovy (injection and pill), Foundayo, and the Zepbound KwikPen |
We're Tracking Coverage Policies
As insurers announce Foundayo-specific policies, we'll update our insurer pages:
Can't wait for insurance? LillyDirect offers Foundayo self-pay starting at $149/month ($149–$299/month by dose; $349 for 14.5/17.2 mg if a refill is late) with no PA required. With commercial insurance, the Lilly savings card can reduce your cost to as low as $25/month.
NEW CMS RULES
2026 PA Regulations
Faster PA Decisions in 2026
From January 1, 2026, Medicare Advantage, Medicaid and CHIP must decide medical prior authorizations within 7 days (72 hours if urgent); the rule excludes drugs, so it does not change Foundayo prior authorization timelines.[7]
New PA Timeline Requirements
| Request Type | Old Rule | New Rule (2026) |
|---|---|---|
| Standard PA decision | Up to 14 days | ≤7 calendar days |
| Expedited/urgent PA | Varied | 72 hours |
Which Plans Are Covered?
These timelines apply to medical-service prior authorizations in Medicare Advantage, Medicaid and CHIP, not to drugs like Foundayo. For a Foundayo PA, most employer and ACA plans must decide within 15 days (72 hours if urgent)—check your specific plan.
If Your PA Takes Longer
If your PA decision exceeds these timeframes:
- Contact your insurer and ask when the decision is due under the federal or state deadline for your plan type
- Ask your doctor to request expedited review if medically urgent
- Consider self-pay while waiting: LillyDirect offers Foundayo starting at $149/month (dose-dependent)
DON'T GIVE UP
What If Denied?
Appeals Work
According to KFF analysis cited by the AMA, over 80% of appealed prior authorization denials are overturned when patients and providers persist[8]—yet only about 1 in 10 patients ever appeal. Most plans give you at least 180 days to file an internal appeal (check your denial letter for your plan's exact deadline).[4]
A denial isn't the end—it's a starting point. Here's what to do:
- Get your denial letter with the specific reason
- Identify what was missing from your documentation
- Gather additional evidence (labs, records, letter of medical necessity)
- Submit internal appeal within your plan's deadline (typically 180 days for most plans)
- If denied again → Request external review (independent third-party review)[4]
Just got denied? Start with our Foundayo Denied guide for immediate next steps, then come back here for your specific denial type.
Common Denial Reasons & How to Appeal
Click your denial reason for specific appeal strategies:
- Denied for "Not Medically Necessary" — The most common denial. Counter with clinical evidence.
- Denied for Step Therapy — Required to try other meds first? Request an exception.
- Denied for BMI Criteria — BMI requirements vary by insurer. See the breakdown.
- Not on Formulary — Foundayo excluded from your plan? Request a formulary exception.
- Missing Lifestyle Documentation — Need proof of diet/exercise attempts? Templates inside.
Need Foundayo while your appeal is processing? Many patients use LillyDirect ($149–$299/mo, no insurance needed) to start treatment while waiting—then switch to insurance once approved.
Plan excludes Foundayo entirely? Other GLP-1s like Wegovy or Mounjaro may have different coverage. Compare alternatives →
Sleep Apnea as Qualifying Comorbidity
OSA (obstructive sleep apnea) is one of the comorbidities that qualifies you for Foundayo's obesity indication at BMI 27-29.9. If OSA is documented as your qualifying comorbidity with ICD-10 code G47.33, some plans that otherwise restrict weight loss coverage may still approve. This isn't a separate indication—Foundayo is approved for obesity/overweight with comorbidities, not for OSA treatment specifically. Learn about self-pay options →
Need help with your appeal? Foundayo appeal guide →
WHAT'S CHANGING
2026 Coverage Outlook
New Options in 2026
While many insurers are tightening GLP-1 coverage, new alternatives have launched: TrumpRx (live since February 5, 2026) and the Medicare GLP-1 Bridge (live July 1, 2026 – December 31, 2027).
Now Live: TrumpRx
TrumpRx Direct-Purchase Program
TrumpRx launched February 5, 2026 as a direct-purchase platform that routes to manufacturer sites like LillyDirect and Novo Nordisk Direct. TrumpRx lists the manufacturers’ own self-pay prices (not a separate, cheaper price):[11]
- Zepbound (vials): $299–$449/month (via LillyDirect)
- Wegovy (pill): Starting at $149/month (via Novo Nordisk)
- Foundayo: $149–$299/month, the same LillyDirect prices—orders go through LillyDirect
No prior authorization required. Cash-pay only—doesn't use insurance.
Now Live: Medicare GLP-1 Bridge
Medicare GLP-1 Bridge Program
People with eligible Part D coverage can get Foundayo for weight loss through the Medicare GLP-1 Bridge, which runs outside Part D, live July 1, 2026 – December 31, 2027. Part D plans and pharmacies don’t opt in, and you don’t enroll separately; your prescriber must get prior authorization.[12]
- Patient cost: $50 per monthly fill
- Covered drugs: Wegovy (injection and pill), Foundayo, and the Zepbound KwikPen
- Eligibility (3 tiers): Age 18+ and BMI ≥35; or BMI ≥30 with HFpEF, uncontrolled high blood pressure or CKD stage 3a+; or BMI ≥27 with prediabetes, a prior heart attack or stroke, or symptomatic PAD
- Not eligible: Not eligible if you have type 2 diabetes, moderate-to-severe obstructive sleep apnea, or noncirrhotic MASH with moderate-to-advanced liver fibrosis (F2–F3), or if your Part D plan paid for a GLP-1 for you at any time in 2026
- After 2027: No successor announced after December 31, 2027 (BALANCE in Part D: Delayed, with no new start date)
Commercial Insurance Trends
Health New England Dropped Coverage
Effective January 1, 2026, Health New England no longer covers GLP-1s for weight loss (Wegovy, Zepbound, Saxenda) for Individual and Small Group members. Diabetes indications still covered. Similar restrictions at Fallon Health and other regional insurers.[13]
2026 Trend: Restrictions Expanding
Many commercial insurers are tightening—not loosening—GLP-1 coverage:
- Aetna: Many plans not covering GLP-1s for weight loss (verify with your specific plan)
- Many BCBS/Cigna/UHC plans: Restricting to diabetes or OSA only
- No grandfathering of existing PAs at renewal
What Should You Do Now?
- Check your 2026 coverage: Call your insurer to ask specifically about Foundayo (brand new drug)
- Get documentation ready: BMI, comorbidities, lifestyle attempts, prior medication trials
- Know your alternatives: LillyDirect (starting at $149/month) available now, no PA required
- Medicare patients: The Medicare GLP-1 Bridge covers Foundayo at $50 per monthly fill if you meet CMS’s eligibility criteria—your prescriber submits a Bridge prior authorization
- Consider OSA pathway: Foundayo isn’t FDA-approved for sleep apnea, but if you have moderate-to-severe sleep apnea, ask your doctor whether Zepbound (approved for OSA) fits—OSA coverage often has different criteria
COMMON PRIOR AUTH QUESTIONS
Frequently Asked Questions
Prior authorization (PA) is insurance approval required before your pharmacy can fill your prescription. The insurer verifies you meet their medical necessity criteria—BMI, comorbidities, and sometimes prior medication trials—before they'll cover the medication.
For most employer and ACA plans, federal rules require a decision within 15 days (one 15-day extension allowed), and many plans decide sooner when documentation is complete. If medically urgent, your doctor can request an expedited review, which must be decided within 72 hours.
Per FDA labeling: BMI ≥30 (obese) or BMI ≥27 with at least one weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, OSA). Some insurers like BCBS Michigan require BMI ≥35.
Hypertension, type 2 diabetes, dyslipidemia (high cholesterol), obstructive sleep apnea (OSA), and cardiovascular disease are the most commonly accepted comorbidities.
Your doctor's office submits the PA—you cannot submit it directly. But you can prepare documentation ahead of time and follow up with your provider to speed the process.
A requirement to try other weight loss medications first before the insurer will approve Foundayo. Most step therapy starts with older, less expensive drugs like phentermine, Contrave, or Qsymia. If you've already tried these medications, document the dates, doses, and outcomes to potentially bypass this requirement.
Yes, with conditions, through the Medicare GLP-1 Bridge. The Bridge (July 1, 2026 – December 31, 2027) covers Foundayo for $50 per monthly fill if you have Part D coverage and meet CMS’s eligibility criteria; your prescriber submits a Bridge prior authorization. If you don’t qualify, LillyDirect self-pay starts at $149/month (dose-dependent).
Most insurers require at least 5% weight loss for renewal (UHC requires 10% for sleep apnea coverage). If you plateau, document all circumstances and appeal—success isn't guaranteed but is possible with strong documentation.
Ask your doctor to request an expedited (urgent) review. Under federal rules for many plans, urgent PA requests must be processed within about 72 hours. Reasons for expedited review include: starting a new job with different insurance soon, upcoming surgery requiring weight loss, or a medical condition worsening without treatment. Your doctor must document the medical urgency.
Yes—and you should. According to KFF analysis cited by the AMA, over 80% of appealed prior authorization denials are overturned when patients and providers persist—yet only about 1 in 10 patients ever appeal. You typically have 180 days to file an internal appeal (check your denial letter for exact deadline). Get the specific denial reason, gather additional documentation, and submit a formal appeal through your insurer. If the internal appeal fails, you can request an external review.
When your PA expires (typically after 6-12 months), you'll need to request a reauthorization. Most insurers require proof of continued medical necessity—including documented weight loss (usually 5% minimum). Start the renewal process 2-4 weeks before expiration to avoid gaps in treatment. Note: Many plans are not grandfathering PAs in 2026, so requirements may change at renewal.
Not for each refill, but you do need a valid PA in place. Once approved, your PA covers refills for the authorization period (usually 6-12 months). When your PA expires, you'll need reauthorization. If you switch pharmacies, change insurance plans, or your doctor increases the dose significantly, a new PA may be required.
WHERE TO GO FROM HERE
Next Steps
Your GLP-1 coverage,
denied approved
✓ Free Templates✓ Premium Support Available
I was denied coverage for...
Get starteddenied approved
Honest Care helps patients fight back:
Evidence-backed appeal letters — plus personalized guidance to appeal with confidence.
"I found Honest Care online and was very impressed with the letter... the appeal worked!"
"My Appeal was approved the next day. Thank you Honest Care!"
References
- U.S. Food and Drug Administration. (April 1, 2026). "FDA Approves First New Molecular Entity Under National Priority Voucher Program." Foundayo (orforglipron) approval announcement. fda.gov
- Eli Lilly and Company. (April 1, 2026). "FDA approves Lilly's Foundayo (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions." investor.lilly.com
- Eli Lilly and Company. (2026). "Authentic Foundayo (orforglipron) Shipped to You." LillyDirect pricing: $149–$299/month. lilly.com/lillydirect
- HealthCare.gov. "How to appeal an insurance company decision." healthcare.gov; decision timelines: 29 CFR 2560.503-1(f) law.cornell.edu
- Kaiser Family Foundation. (2026). "Examining Prior Authorization in Health Insurance." Analysis of PA requirements and success rates. kff.org
- Peterson-KFF Health System Tracker. (2026). "Insurer strategies to control costs associated with weight loss drugs." healthsystemtracker.org
- Centers for Medicare & Medicaid Services. (January 2024). "CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F)." Requires 72-hour expedited and 7-day standard PA decisions for medical services in Medicare Advantage, Medicaid and CHIP; excludes drugs. cms.gov
- American Medical Association. (2024). "Over 80% of Prior Auth Appeals Succeed. Why Aren't There More?" Analysis based on Medicare Advantage data showing high appeal success rates. ama-assn.org
- Blue Cross Blue Shield of Michigan. (2024). "Alert: Changes to Weight Loss Drug Coverage." providerinfo.bcbsm.com (PDF)
- American Medical Association. (2024). "2024 AMA Prior Authorization Physician Survey." ama-assn.org (PDF)
- CNBC. (February 5, 2026). "White House launches direct-to-consumer drug site TrumpRx." Directs users to manufacturer direct-to-consumer platforms. cnbc.com
- Centers for Medicare & Medicaid Services. (December 2025). "Medicare GLP-1 Bridge." Program runs July 1, 2026 – December 31, 2027. Covers Wegovy (injection and pill), Foundayo, and the Zepbound KwikPen at $50 per monthly fill. cms.gov
- Health New England. (2026). "GLP-1 Coverage Update." Coverage for weight loss GLP-1s ended January 1, 2026 for Individual and Small Group members. healthnewengland.org
Last updated October 6, 2026 · Key facts verified October 5, 2026
Disclaimer
The information on this page is for educational and informational purposes only and is not intended as medical advice. Honest Care does not provide medical diagnosis, treatment, or individualized recommendations. Always seek the advice of your physician or other qualified healthcare professional regarding any medical condition or treatment.
While this content has been reviewed for accuracy and balance, new evidence may emerge after publication. Drug availability, indications, and insurance coverage can change over time. Honest Care makes no warranties as to completeness or currentness of the information and is not responsible for decisions made based on this content.